Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
Key Information
Due Date: January 7, 2027
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: Not Specified
Funding Type: Grant, Government
Match Required: No
Contact Info:
grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
The second aim is to attract skilled scientists who can explore the dynamic changes caused by these agents. The focus is to unravel how these agents affect cancer risk beyond short-term outcomes like weight loss and diabetes.
Current data suggests these agents might have a dual effect: increasing the risk of certain obesity-linked cancers while reducing the risk of others. The grant is structured to further this research and deepen our understanding of these impacts.
Key Dates
Open Date: August 24, 2023
Application Due Date: January 7, 2027
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses